Komori
General Meetings of Shareholders2927AFC-HD AMS Life Science Co.,Ltd.Foods

Notice of Convocation of the 2026 Annual General Meeting of Shareholders

The 46th Annual General Meeting of Shareholders will be held on 25 November 2026, at which proposals will be submitted concerning the year-end dividend and the election of 9 directors and 3 directors who are Audit and Supervisory Committee Members. Among the candidates for Audit and Supervisory Committee Members, Miyamoto Daisuke (宮本大輔) will be newly appointed.

Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (46th fiscal year)
2026
Nov 25
Date and time23 days from this disclosure to the meeting
Matters for resolution3 items

  1. Appropriation of surplus

  2. Proposal to elect 9 directors (excluding directors who are Audit and Supervisory Committee Members)

  3. Election of 3 Directors serving as Audit and Supervisory Committee Members

Shareholder Proposal

None (not specified)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
12Nominees
1New
2Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (46th fiscal year)
Date and time10:30 a.m. on Wednesday, 25 November 2026
Matters for resolutionAppropriation of surplus, Proposal to elect 9 directors (excluding directors who are Audit and Supervisory Committee Members), Election of 3 Directors serving as Audit and Supervisory Committee Members
Shareholder ProposalNone (not specified)
Director nominee12 nominees, including 1 new nominee and 2 outside directors
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To hold the General Meeting of Shareholders. The terms of office of the incumbent directors will expire. The terms of office of the incumbent Audit and Supervisory Committee Members will expire, and the consent of the Audit and Supervisory Committee has been obtained.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 2026 Annual General Meeting of Shareholders | AFC-HD AMS Life Science Co.,Ltd. (2927) timely disclosure | Komori